Systematic review: efficacy and safety of switching patients between reference and biosimilar infliximab von Feagan, Brian G., Lam, Gordon, Ma, Christopher, Lichtenstein, Gary R.

Volltext

Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases—A Clinical Practice Update: Commentary von Hanauer, Stephen B., Sandborn, William J., Lichtenstein, Gary R.

Volltext

Reliability and Initial Validation of the Ulcerative Colitis Endoscopic Index of Severity von Travis, Simon P.L, Schnell, Dan, Krzeski, Piotr, Abreu, Maria T, Altman, Douglas G, Colombel, Jean–Frédéric, Feagan, Brian G, Hanauer, Stephen B, Lichtenstein, Gary R, Marteau, Philippe R, Reinisch, Walter, Sands, Bruce E, Yacyshyn, Bruce R, Schnell, Patrick, Bernhardt, Christian A, Mary, Jean–Yves, Sandborn, William J

Volltext

Infliximab for Crohn's Disease: More Than 13 Years of Real-world Experience von Lichtenstein, Gary R, Feagan, Brian G, Cohen, Russell D, Salzberg, Bruce A, Safdi, Michael, Popp, John W, Langholff, Wayne, Sandborn, William J

Volltext

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) von Travis, Simon P L, Schnell, Dan, Krzeski, Piotr, Abreu, Maria T, Altman, Douglas G, Colombel, Jean-Frédéric, Feagan, Brian G, Hanauer, Stephen B, Lémann, Marc, Lichtenstein, Gary R, Marteau, Phillippe R, Reinisch, Walter, Sands, Bruce E, Yacyshyn, Bruce R, Bernhardt, Christian A, Mary, Jean-Yves, Sandborn, William J

Volltext

Lifetime Economic Burden of Crohn’s Disease and Ulcerative Colitis by Age at Diagnosis von Lichtenstein, Gary R., MD, Shahabi, Ahva, MPH, PhD, Seabury, Seth A., PhD, Lakdawalla, Darius N., PhD, Espinosa, Oliver Díaz, PhD, Green, Sarah, BA, Brauer, Michelle, BS, Baldassano, Robert N., MD

Volltext

Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative Colitis von Lewis, James D., Chuai, Shaokun, Nessel, Lisa, Lichtenstein, Gary R., Aberra, Faten N., Ellenberg, Jonas H.

Volltext

American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease von Lichtenstein, Gary R., Abreu, Maria T., Cohen, Russell, Tremaine, William

Volltext

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis von Rutgeerts, Paul, Sandborn, William J, Feagan, Brian G, Reinisch, Walter, Olson, Allan, Johanns, Jewel, Travers, Suzanne, Rachmilewitz, Daniel, Hanauer, Stephen B, Lichtenstein, Gary R, de Villiers, Willem J.S, Present, Daniel, Sands, Bruce E, Colombel, Jean Frédéric

Volltext

American Gastroenterological Association Institute Medical Position Statement on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease von Lichtenstein, Gary R., Abreu, Maria T., Cohen, Russell, Tremaine, William

Volltext

The TREAT™ Registry – Evolution of Knowledge from 1999 to 2017: Lessons Learned von Lichtenstein, Gary R., MD

Volltext

Association of 6-Thioguanine Nucleotide Levels and Inflammatory Bowel Disease Activity: A Meta-Analysis von Osterman, Mark T., Kundu, Rabi, Lichtenstein, Gary R., Lewis, James D.

Volltext

Long‐term infliximab maintenance therapy for ulcerative colitis: The ACT‐1 and ‐2 extension studies von Reinisch, Walter, Sandborn, William J., Rutgeerts, Paul, Feagan, Brian G., Rachmilewitz, Daniel, Hanauer, Stephen B., Lichtenstein, Gary R., de Villiers, Willem J.S., Blank, Marion, Lang, Yinghua, Johanns, Jewel, Colombel, Jean Frédéric, Present, Daniel, Sands, Bruce E.

Volltext

Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s disease von Rutgeerts, Paul, Feagan, Brian G., Lichtenstein, Gary R., Mayer, Lloyd F., Schreiber, Stefan, Colombel, Jean Frederic, Rachmilewitz, Daniel, Wolf, Douglas C., Olson, Allan, Bao, Weihang, Hanauer, Stephen B.

Volltext

Rosiglitazone for Active Ulcerative Colitis: A Randomized Placebo-Controlled Trial von Lewis, James D, Lichtenstein, Gary R, Deren, Julius J, Sands, Bruce E, Hanauer, Stephen B, Katz, Jeffrey A, Lashner, Bret, Present, Daniel H, Chuai, Shaokun, Ellenberg, Jonas H, Nessel, Lisa, Wu, Gary D

Volltext

Effect of Once- or Twice-Daily MMX Mesalamine (SPD476) for the Induction of Remission of Mild to Moderately Active Ulcerative Colitis von Lichtenstein, Gary R, Kamm, Michael A, Boddu, Prabhakar, Gubergrits, Natalya, Lyne, Andrew, Butler, Todd, Lees, Kirstin, Joseph, Raymond E, Sandborn, William J

Volltext

Infliximab vs. Adalimumab for UC: Is There A Difference? von Osterman, Mark T., MD MSCE, Lichtenstein, Gary R., MD

Volltext

Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis von Rubin, David T., Reinisch, Walter, Greuter, Thomas, Kotze, Paulo G., Pinheiro, Marcia, Mundayat, Rajiv, Maller, Eric, Fellmann, Marc, Lawendy, Nervin, Modesto, Irene, Vavricka, Stephan R., Lichtenstein, Gary R.

Volltext

Diagnosing and Treating Noncardiac Chest Pain von Lichtenstein, Gary R

Volltext

Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients von Aberra, Faten N, Lewis, James D, Hass, David, Rombeau, John L, Osborne, Benjamin, Lichtenstein, Gary R

Volltext